NDC 69238-1248 – Memantine and Donepezil Hydrochlorides Extended-release
Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Oral
Product NDC69238-1248
Product details
- Brand name
- Memantine and Donepezil Hydrochlorides Extended-release
- Generic name
- Memantine and Donepezil
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208328
- Marketed since
- February 1, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Memantine Hydrochloride 14 mg/1
- Donepezil Hydrochloride 10 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 69238-1248-3 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1248-3) | Feb 1, 2017 |
| 69238-1248-9 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1248-9) | Feb 1, 2017 |
Other Memantine and Donepezil Hydrochlorides Extended-release products
- 69238-1247 Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1552 Memantine Hydrochloride 7 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1553 Memantine Hydrochloride 21 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 73190-004 Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · AvKARE